LivingGLP1
Study S001036

Evaluation of the Single-Use Pre-Filled Autoinjector

Registration

Registration
NCT02349802
Acronym
BCB119
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE1
Masking
NONE
Status
COMPLETED
Enrollment
3052
Start
2013-02
Primary completion
2013-12
Lead sponsor
AstraZeneca
Conditions
Healthy Subjects
Interventions
DRUG:Auto-injector with exenatide suspension; DRUG:Syringe with exenatide suspension
Results posted
FALSE

Registered primary outcomes

  • Number of device-related failure injections [10 week study]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.